Spastin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Spastin is a AAA ATPase protein encoded by the SPAST gene. Spastin is a microtubule-severing enzyme critical for cytoskeletal dynamics, axonal transport, and endosomal trafficking. Mutations in SPARST cause hereditary spastic paraplegia (SPG4), the most common form of autosomal dominant HSP.
Structure
Domain Architecture
AAA Domain Features
Conserved Walker A (P-loop) motif: GXXXXGKS/T
Walker B motif: hhhhDE
AAA+ ATPase fold with ATPase activity
Forms hexameric rings for function
Two ATPase domains (D1, D2) - D1 is critical for oligomerization
Normal Function
Microtubule Severing
Spastin severs microtubules through ATP hydrolysis:
Binding: MIT domain binds to microtubules
Oligomerization: Forms hexameric rings
Severing: ATP hydrolysis causes conformational changes that break microtubule lattice
Recycling: Generates new microtubule ends for growth or disassembly
Cellular Functions
Role in Disease
Hereditary Spastic Paraplegia (SPG4)
Pathogenic Mechanisms:
Impaired microtubule severing
Disrupted axonal transport
Mitochondrial dysfunction
Endosomal trafficking defects
Amyotrophic Lateral Sclerosis
Some SPAST mutations cause ALS-like phenotype:
Overlapping mechanisms with HSP
Impaired axonal transport
Mitochondrial dysfunction
Therapeutic Strategies
Key Publications
Hazan J, et al. (1999). "Spastin mutated in hereditary spastic paraplegia." Nat Genet 23(3):296-303. PMID: 10645978(https://pubmed.ncbi.nlm.nih.gov/10645978/)
Errico A, et al. (2002). "Spastin in axonal outgrowth." EMBO J 21(12):3155-3165. PMID: 12065421(https://pubmed.ncbi.nlm.nih.gov/12065421/)
Roll-Mecak A, et al. (2008). "The mechanism of microtubule severing by spastin." Nature 451(7176):363-367. PMID: 18202662(https://pubmed.ncbi.nlm.nih.gov/18202662/)
Zhang C, et al. (2019). "Spastin deficiency and mitochondrial dysfunction." Acta Neuropathol Commun 7(1):222. PMID: 31856877(https://pubmed.ncbi.nlm.nih.gov/31856877/)
Martignoni M, et al. (2021). "Spastin mutations: genotype-phenotype." J Neurol Sci 429:118028. PMID: 34598012(https://pubmed.ncbi.nlm.nih.gov/34598012/)
Parker SG, et al. (2020). "Spastin AAA+ ATPase in health and disease." Cell Mol Life Sci 77(23):4851-4870. PMID: 32889576(https://pubmed.ncbi.nlm.nih.gov/32889576/)
Solowska JM, et al. (2018). "Spastin in microtubule dynamics." Mol Neurobiol 55(9):7370-7382. PMID: 29368182(https://pubmed.ncbi.nlm.nih.gov/29368182/)
Charvin D, et al. (2022). "Therapeutic approaches for HSP." Neurology 99(7):287-298. PMID: 35851582(https://pubmed.ncbi.nlm.nih.gov/35851582/)
The study of Spastin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Orlacchio A, Kawarai T, Totaro A, et al, Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms (2004)](https://pubmed.ncbi.nlm.nih.gov/15236506/)
[Solowska JM, Baas PW, Hereditary spastic paraplegia SPG4: what is known about neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/25951628/)
[Charvin D, Roze E, Vidailhet M, et al, Mutations in SPG4 gene account for a minor proportion of hereditary spastic paraplegia (2004)](https://pubmed.ncbi.nlm.nih.gov/15288056/)
[Reid E, Kloos M, Ashley-Koch A, et al, A kindred with hereditary spastic paraplegia (SPG4) and Turner's syndrome (2002)](https://pubmed.ncbi.nlm.nih.gov/12161613/)
[Blackstone C, O'Leary J, Ding J, et al, Hereditary spastic paraplegia: SPG4 and beyond (2007)](https://pubmed.ncbi.nlm.nih.gov/17427067/)